Skip to main content

Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Margarita Navarro Pérez

Margarita Navarro Pérez

Margarita Navarro Pérez

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Jordi Grau Rios

Jordi Grau Rios

Software Engineering Unit
Digital Transformation Directorate
Read more
Montserrat Solé Piñol

Montserrat Solé Piñol

Postdoctoral researcher
Neurodegenerative Diseases
Read more
Neus Grau Novellas

Neus Grau Novellas

Tècnic de recerca
Clinical Trials Management Unit
Commercial and Academic Clinical Research
Read more
Julia Sanchon Soler

Julia Sanchon Soler

Gestió i Administració
Secretariat for Governance and Science Policy
Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.